ロード中...
Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC
BACKGROUND: Patients with human papillomavirus (HPV+) head and neck squamous cell carcinoma (HNSCC) have superior prognoses compared with patients with HPV− HNSCC and strategies for treatment de-escalation are under investigation for the HPV+ setting. However, the survival advantage associated with...
保存先:
| 出版年: | J Immunother Cancer |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7978288/ https://ncbi.nlm.nih.gov/pubmed/33737336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001259 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|